These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 11191694

  • 1. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS, Chang W, Lee HK, Cook MS.
    J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
    [Abstract] [Full Text] [Related]

  • 2. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C, Planès S, Logerot S, Villier C, Mallaret M.
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
    Chungh DS, Kim BN, Cho SC.
    J Psychopharmacol; 2005 Jul; 19(4):422-5. PubMed ID: 15982999
    [Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ, Hopwood MJ, Morris PL.
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [Abstract] [Full Text] [Related]

  • 6. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M, Adityanjee, Jampala C.
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract] [Full Text] [Related]

  • 7. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB.
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR, Mack JE, Torres RA.
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [Abstract] [Full Text] [Related]

  • 9. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA, de Jonghe-Rouleau AP, Stienstra-Liem LH.
    Ned Tijdschr Geneeskd; 2004 Sep 11; 148(37):1801-4. PubMed ID: 15495506
    [Abstract] [Full Text] [Related]

  • 10. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R, Trappler B, Ng YK, Leeman CP.
    Ann Pharmacother; 1996 Sep 11; 30(7-8):775-8. PubMed ID: 8826559
    [Abstract] [Full Text] [Related]

  • 11. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R, Jäger M, Hofschuster E, Dobmeier P, Möller HJ.
    Pharmacopsychiatry; 2002 May 11; 35(3):119-21. PubMed ID: 12107858
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA, Zivot J, Ariano RE.
    Ann Pharmacother; 2011 Sep 11; 45(9):e50. PubMed ID: 21878660
    [Abstract] [Full Text] [Related]

  • 13. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec 11; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 14. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S, Buckley P.
    Am J Psychiatry; 1998 Aug 11; 155(8):1113-6. PubMed ID: 9699705
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL, Taylor WH, Ware MR.
    Psychopharmacol Bull; 2001 Aug 11; 35(3):49-54. PubMed ID: 12397878
    [Abstract] [Full Text] [Related]

  • 16. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA, Kuiper J, Verwey B.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract] [Full Text] [Related]

  • 17. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T.
    Seishin Shinkeigaku Zasshi; 1998 Jan 15; 100(6):387-97. PubMed ID: 9745353
    [Abstract] [Full Text] [Related]

  • 18. [Neuroleptic malignant syndrome in users of risperidone].
    Kroon JG.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):157-8; author reply 158. PubMed ID: 15693594
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 20. Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report.
    Motomura E, Tanii H, Usami A, Ohoyama K, Nakagawa M, Okada M.
    J Neuropsychiatry Clin Neurosci; 2012 Jan 15; 24(2):E38-9. PubMed ID: 22772697
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.